Oskar Hagberg

Medicine & Life Sciences

1. Urinary Bladder Neoplasms 100%
2. Sweden 46%
3. Cystectomy 45%
4. Survival 44%
5. Population 40%
6. Registries 23%
7. Neoplasms 22%
8. Cancer Survivors 20%
9. Databases 18%
10. Urinary Diversion 15%
11. Lymphoma 15%
12. Recurrence 15%
13. Lymphoma, Large B-Cell, Diffuse 14%
14. Rituximab 13%
15. Hematuria 13%
16. Therapeutics 12%
17. Muscles 11%
18. Incidence 11%
19. Anus Neoplasms 11%
20. Clostridium botulinum type B 11%
21. Radiotherapy 11%
22. Carcinoma 11%
23. Guidelines 10%
24. Survivors 10%
25. Delivery of Health Care 10%
26. Holidays 9%
27. Urologic Neoplasms 9%
28. pazopanib 9%
29. Sodium Nitrite 9%
30. Incisional Hernia 8%
31. Drug Therapy 8%
32. Confidence Intervals 8%
33. Perioperative Care 8%
34. Second Primary Neoplasms 7%
35. Thromboembolism 7%
36. Follicular Lymphoma 7%
37. Burkitt Lymphoma 7%
38. Gastrointestinal Stromal Tumors 7%
39. Atmosphere 7%
40. Neoplasm Metastasis 7%
41. Mortality 7%
42. Sodium Chloride 7%
43. Neurotoxins 7%
44. DNA-Directed DNA Polymerase 6%
45. Anal Canal 6%
46. Time-to-Treatment 6%
47. Decision Making 6%
48. Solar System 6%
49. Venous Thromboembolism 6%
50. Hernia 6%